Global Pertussis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

According to APO Research, The global Pertussis Vaccine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pertussis Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pertussis Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Pertussis Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Pertussis Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Pertussis Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics and Chengdu Institute of Biological Products, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pertussis Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Pertussis Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pertussis Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pertussis Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pertussis Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pertussis Vaccine sales, projected growth trends, production technology, application and end-user industry.


Pertussis Vaccine Segment by Company

Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
KM Biologics
Chengdu Institute of Biological Products

Pertussis Vaccine Segment by Type

Whole-cell Vaccines
Acellular Vaccines

Pertussis Vaccine Segment by Application

12 Months Below
12 Months Above

Pertussis Vaccine Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pertussis Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Pertussis Vaccine Market Size, 2020 VS 2024 VS 2031
1.3 Global Pertussis Vaccine Market Size Estimates and Forecasts (2020-2031)
1.4 Global Pertussis Vaccine Sales Estimates and Forecasts (2020-2031)
1.5 Global Pertussis Vaccine Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Pertussis Vaccine Market Dynamics
2.1 Pertussis Vaccine Industry Trends
2.2 Pertussis Vaccine Industry Drivers
2.3 Pertussis Vaccine Industry Opportunities and Challenges
2.4 Pertussis Vaccine Industry Restraints
3 Pertussis Vaccine Market by Manufacturers
3.1 Global Pertussis Vaccine Revenue by Manufacturers (2020-2025)
3.2 Global Pertussis Vaccine Sales by Manufacturers (2020-2025)
3.3 Global Pertussis Vaccine Average Sales Price by Manufacturers (2020-2025)
3.4 Global Pertussis Vaccine Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Pertussis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Pertussis Vaccine Manufacturers, Product Type & Application
3.7 Global Pertussis Vaccine Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Pertussis Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pertussis Vaccine Players Market Share by Revenue in 2024
3.8.3 2024 Pertussis Vaccine Tier 1, Tier 2, and Tier 3
4 Pertussis Vaccine Market by Type
4.1 Pertussis Vaccine Type Introduction
4.1.1 Whole-cell Vaccines
4.1.2 Acellular Vaccines
4.2 Global Pertussis Vaccine Sales by Type
4.2.1 Global Pertussis Vaccine Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Pertussis Vaccine Sales by Type (2020-2031)
4.2.3 Global Pertussis Vaccine Sales Market Share by Type (2020-2031)
4.3 Global Pertussis Vaccine Revenue by Type
4.3.1 Global Pertussis Vaccine Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Pertussis Vaccine Revenue by Type (2020-2031)
4.3.3 Global Pertussis Vaccine Revenue Market Share by Type (2020-2031)
5 Pertussis Vaccine Market by Application
5.1 Pertussis Vaccine Application Introduction
5.1.1 12 Months Below
5.1.2 12 Months Above
5.2 Global Pertussis Vaccine Sales by Application
5.2.1 Global Pertussis Vaccine Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Pertussis Vaccine Sales by Application (2020-2031)
5.2.3 Global Pertussis Vaccine Sales Market Share by Application (2020-2031)
5.3 Global Pertussis Vaccine Revenue by Application
5.3.1 Global Pertussis Vaccine Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Pertussis Vaccine Revenue by Application (2020-2031)
5.3.3 Global Pertussis Vaccine Revenue Market Share by Application (2020-2031)
6 Global Pertussis Vaccine Sales by Region
6.1 Global Pertussis Vaccine Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Pertussis Vaccine Sales by Region (2020-2031)
6.2.1 Global Pertussis Vaccine Sales by Region (2020-2025)
6.2.2 Global Pertussis Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Pertussis Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Pertussis Vaccine Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Pertussis Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Pertussis Vaccine Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Pertussis Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Pertussis Vaccine Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Pertussis Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Pertussis Vaccine Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Pertussis Vaccine Revenue by Region
7.1 Global Pertussis Vaccine Revenue by Region
7.1.1 Global Pertussis Vaccine Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Pertussis Vaccine Revenue by Region (2020-2025)
7.1.3 Global Pertussis Vaccine Revenue by Region (2026-2031)
7.1.4 Global Pertussis Vaccine Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Pertussis Vaccine Revenue (2020-2031)
7.2.2 North America Pertussis Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Pertussis Vaccine Revenue (2020-2031)
7.3.2 Europe Pertussis Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Pertussis Vaccine Revenue (2020-2031)
7.4.2 Asia-Pacific Pertussis Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Pertussis Vaccine Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Pertussis Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Sanofi Pasteur
8.1.1 Sanofi Pasteur Comapny Information
8.1.2 Sanofi Pasteur Business Overview
8.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
8.1.5 Sanofi Pasteur Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 GSK Pertussis Vaccine Product Portfolio
8.2.5 GSK Recent Developments
8.3 Mitsubishi Tanabe Pharma
8.3.1 Mitsubishi Tanabe Pharma Comapny Information
8.3.2 Mitsubishi Tanabe Pharma Business Overview
8.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
8.3.5 Mitsubishi Tanabe Pharma Recent Developments
8.4 Wuhan Institute of Biological Products
8.4.1 Wuhan Institute of Biological Products Comapny Information
8.4.2 Wuhan Institute of Biological Products Business Overview
8.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
8.4.5 Wuhan Institute of Biological Products Recent Developments
8.5 Walvax Biotechnology
8.5.1 Walvax Biotechnology Comapny Information
8.5.2 Walvax Biotechnology Business Overview
8.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
8.5.5 Walvax Biotechnology Recent Developments
8.6 Minhai Biotechnology
8.6.1 Minhai Biotechnology Comapny Information
8.6.2 Minhai Biotechnology Business Overview
8.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
8.6.5 Minhai Biotechnology Recent Developments
8.7 KM Biologics
8.7.1 KM Biologics Comapny Information
8.7.2 KM Biologics Business Overview
8.7.3 KM Biologics Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 KM Biologics Pertussis Vaccine Product Portfolio
8.7.5 KM Biologics Recent Developments
8.8 Chengdu Institute of Biological Products
8.8.1 Chengdu Institute of Biological Products Comapny Information
8.8.2 Chengdu Institute of Biological Products Business Overview
8.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
8.8.5 Chengdu Institute of Biological Products Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Pertussis Vaccine Value Chain Analysis
9.1.1 Pertussis Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pertussis Vaccine Production Mode & Process
9.2 Pertussis Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pertussis Vaccine Distributors
9.2.3 Pertussis Vaccine Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings